ALVR | AlloVir, Inc. Stock Overview

(Stock Exchange: NASDAQ)

Day's Range	0.5600 - 0.6360
52 Week Range	0.5300 - 2.4850
Beta	0.43
Implied Volatility	370.29%
IV Rank	60.51%
Day's Volume	644,910
Average Volume	285,600
Shares Outstanding	115,537,000
Market Cap	65,867,644
Sector	Healthcare
Industry	Biotechnology
IPO Date	2020-07-30

Valuation
Profitability
Growth
Health
P/E Ratio	-0.65
Forward P/E Ratio	N/A
EPS	-0.88
1YR Price Target	N/A
Dividend Yield	N/A
Dividend Per Share	N/A
Dividend ExDate	N/A
Dividend PayDate	N/A
Employees	8
Country	USA
Website	ALVR

Allovir, Inc., a clinical-stage cell therapy company, engages in the research and development of allogeneic, off-the-shelf multi-virus specific T cell (VST) therapies to prevent and treat devastating viral-associated diseases. The company's lead product is posoleucel, an allogeneic, off-the-shelf VST therapy, to treat BK virus, cytomegalovirus, adenovirus, Epstein-Barr virus, human herpesvirus 6, and JC virus. Its preclinical and clinical development product candidates include ALVR106 for the respiratory syncytial virus, influenza, parainfluenza virus, and human metapneumovirus; ALVR109 to treat SARS-CoV-2 and COVID-19; ALVR107 for treating hepatitis B; and ALVR108. The company was formerly known as ViraCyte, Inc. and changed its name to Allovir, Inc. in May 2019. Allovir, Inc. was founded in 2013 and is based in Waltham, Massachusetts.

ALVR's peers: ADCT, ANEB, MLYS, ANTX, AVTE, ADAG, FIXX, STOK, BCEL, BDTX, FDMT, ACRV, CGEM, AGIO, CRNX, INBX, MRUS, LYEL, KRON, ANAB, BYSI, DSGN, INKT, RVSN

*Chart delayed

Analyzing fundamentals for ALVR we got that it has weak fundamentals where Valuation is considered to be significantly overvalued, Profitability is unacceptably poor, Growth is desperately bad and Health is weak. For more detailed analysis please see ALVR Fundamentals page.

Watching at ALVR technicals we can see that long-term trend is bearish, the same as bearish middle-term trend, as well as bearish short-term trend. More technicals details can be found on ALVR Technicals page.